Skip to main content

Table 1 Patient characteristics overall and according to obesity and type 2 diabetes status

From: Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH

 

All patients (n = 347)

Obese (n = 249)

Non-obese (n = 98)

T2D (n = 194)

Non-T2D (n = 151)a

Mean age, years (SD)

55.6 (11.9)

55.2 (11.2)

56.9 (13.5)

57.5 (11.1)

53.3 (12.5)

Sex, n (%)

 Male

186 (53.6)

141 (56.6)

45 (45.9)

104 (53.6)

80 (53.0)

 Female

161 (46.4)

108 (43.4)

53 (54.1)

90 (46.4)

71 (47.0)

Ethnicity, n (%)

 White/Caucasian

271 (78.1)

196 (78.7)

75 (76.5)

147 (75.8)

122 (80.8)

 African American

28 (8.1)

23 (9.2)

5 (5.1)

18 (9.3)

10 (6.6)

 Hispanic/Latino

18 (5.2)

13 (5.2)

5 (5.1)

14 (7.2)

4 (2.6)

 Other

30 (8.6)

17 (6.8)

13 (13.3)

15 (7.7)

15 (9.9)

Mean BMI, kg/m2 (SD)

33.2 (5.8)

35.7 (4.8)

26.8 (2.7)

34.0 (6.1)

32.2 (5.3)

Comorbidities, n (%)b

(n = 345)

(n = 249)

(n = 96)

(n = 194)

(n = 151)

 T2D

194 (56.2)

145 (58.2)

49 (51.0)

194 (100)

0

 Hypertension

167 (48.4)

117 (47.0)

50 (52.1)

105 (54.1)

62 (41.1)

 Myocardial infarction

20 (5.8)

13 (5.2)

7 (7.3)

15 (7.7)

5 (3.3)

Fibrosis stage, n (%)

 F0

27 (7.8)

18 (7.2)

9 (9.2)

16 (8.2)

11 (7.3)

 F1

68 (19.6)

48 (19.3)

20 (20.4)

33 (17.0)

34 (22.5)

 F2

58 (16.7)

45 (18.1)

13 (13.3)

32 (16.5)

26 (17.2)

 F3

57 (16.4)

33 (13.3)

24 (24.5)

37 (19.1)

20 (13.2)

 F4

51 (14.7)

36 (14.5)

15 (15.3)

29 (14.9)

22 (14.6)

 Don’t know

86 (24.8)

69 (27.7)

17 (17.3)

47 (24.2)

38 (25.2)

  1. BMI body mass index, SD standard deviation, T2D type 2 diabetes
  2. aDon’t know: n = 2
  3. bOccurring in > 5% of patients. Patients could have ≥ 1 comorbidity